Yangwei Wang
Impact in
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Dialysis and Renal Disease Management 5
- Chronic Kidney Disease and Diabetes 4
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Manyu Luo (9 shared papers)Lining Miao (7 shared papers)Wenpeng Cui (15 shared papers)Lining Miao (11 shared papers)Lu Cai (4 shared papers)Lili Kong (4 shared papers)Yonggang Wang (3 shared papers)Jing Sun (5 shared papers)
- Journals
- Advanced Robotics (2 papers)Journal of Cellular and Molecular Medicine (2 papers)International Journal of Cancer (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Rapid Prototyping Journal (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yangwei Wang
55 papers receiving 939 citations
Peers
Comparison fields: 5 of 122
- Nephrology 80
- Molecular Medicine 57
- Geriatrics and Gerontology 37
- Clinical Biochemistry 65
- Pharmacology 110
Countries citing papers authored by Yangwei Wang
This map shows the geographic impact of Yangwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangwei Wang more than expected).
Fields of papers citing papers by Yangwei Wang
This network shows the impact of papers produced by Yangwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangwei Wang. The network helps show where Yangwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 101 | |
| 2 | 2015 | 84 | |
| 3 | 2017 | 68 | |
| 4 | 2013 | 55 | |
| 5 | 2019 | 52 | |
| 6 | 2018 | 52 | |
| 7 | 2013 | 48 | |
| 8 | 2017 | 44 | |
| 9 | 2011 | 38 | |
| 10 | 2024 | 34 | |
| 11 | 2018 | 31 | |
| 12 | 2013 | 27 | |
| 13 | 2013 | 24 | |
| 14 | 2017 | 20 | |
| 15 | 2023 | 19 | |
| 16 | 2023 | 17 | |
| 17 | 2023 | 17 | |
| 18 | 2024 | 16 | |
| 19 | 2018 | 15 | |
| 20 | 2021 | 14 |
About Yangwei Wang
Yangwei Wang is a scholar working on Nephrology, Cancer Research, Cell Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 948 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (5 papers), Chronic Kidney Disease and Diabetes (4 papers), Prosthetics and Rehabilitation Robotics (4 papers), Cancer-related molecular mechanisms research (4 papers), Muscle activation and electromyography studies (4 papers), Kidney Stones and Urolithiasis Treatments (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Robot Manipulation and Learning (3 papers). The work is most often cited by research in Nephrology (80 citations), Molecular Medicine (57 citations), Geriatrics and Gerontology (37 citations), Clinical Biochemistry (65 citations) and Pharmacology (110 citations). Yangwei Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Manyu Luo, Lining Miao, Wenpeng Cui, Lining Miao, Lu Cai, Lili Kong, Yonggang Wang, Jing Sun, Yan Lou and Yi Tan. Their work appears in journals such as Advanced Robotics, Journal of Cellular and Molecular Medicine, International Journal of Cancer, Oxidative Medicine and Cellular Longevity and Rapid Prototyping Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.